Press Release

September 22, 2006

Med Ad News is excited to announce Paul LeVine, Vice President of Analytics at InfoMedics and Darren Ostmeyer, Product Manager for ROZEREM™ at Takeda Pharmaceuticals as co-presenters of "Structured Insight into Patients: Learning What Patients Really Think about Your Product" at the Patient-Centric Marketing Conference on Wednesday, September 27.

The case study presented will be based on an actual program conducted by InfoMedics for Takeda, and will demonstrate methods that many leading brands and companies have used to improve their market share and ROI through patient-physician communications.

"We will provide attendees with a deeper understanding of how gathering patient feedback and communicating it to physicians in real-time is crucial to improving a brand's market share and more positive patient reported outcomes," explains LeVine. "We will analyze some of the recent patient-centric marketing initiatives that InfoMedics has deployed to support ROZEREM, and also demonstrate the quantitative and qualitative impact of these programs in general."

Paul LeVine has worked for nearly 20 years in a variety of settings within healthcare, including the pharmaceutical and managed care sectors, as well as in government. Having spent the majority of his career focused on the analysis of data and the ability to leverage information to inform business decisions, LeVine is also an experienced pharmaceutical market researcher and an accomplished writer. He has authored more than two dozen articles and abstracts for both scientific and trade publications.

Darren Ostmeyer has more than 18 years of leadership experience building brands and guiding sales teams in the pharmaceutical industry. Ostmeyer joined Takeda in November 1998 and has held sales management and marketing positions including District Sales Manager, Project Manager, Regional Sales Director and Senior Product Manager. Currently, Darren is responsible for the development and execution of personal and non-personal promotional materials, needed to support the promotion of ROZEREMT (ramelteon), a treatment for insomnia.

InfoMedics is the only pharmaceutical services provider with a proven platform that improves the quality of the relationship between physicians and their patients; a platform designed to deliver better communications and feedback on medication satisfaction. The patient experience data delivered to physicians by InfoMedics provides specific information that benefits physicians, at the point-of-care, to optimize patient outcomes and improve compliance. InfoMedics programs facilitate the communication channel between physicians and patients around the pharmaceutical brand, enhancing product awareness and accelerating market share growth.

Takeda Pharmaceuticals North America is a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, the largest pharmaceutical company in Japan. In the United States, Takeda currently markets oral diabetes, insomnia, cholesterol-lowering and gastroenterology treatments, and through the Takeda Global Research & Development Center, Inc., the company has a robust pipeline with compounds in development for diabetes, cardiovascular disease and other conditions. Takeda is committed to striving toward better health for individuals and progress in medicine by developing superior pharmaceutical products.

The September conference, designed by an advisory board of senior pharmaceutical marketers and the editorial team of Med Ad News, will be held at the Princeton Marriott Hotel and Conference Center at Forrestal in Princeton, NJ. For more information, please view the conference website www.patientcentricmarketing.com.

For additional information contact:
Jesse Ciccone
Matter Communications
978-499-9250 x230
jesse@matternow.com

Amy Weickert
InfoMedics, Inc.
781-904-4512
aweickert@infomedics.com